ZEUS Scientific Acquires Synthetic Peptides from Sheba Medical Center’s Tech Transfer Co.
The company intends to utilize these innovative multi-epitope citrullinated peptides for the development of a new generation of immunoassays designed to measure autoantibodies as an aid in the diagnosis of Rheumatoid Arthritis.